CordovaCann Corp.
LVRLF
$0.059
-$0.011-15.71%
| Weiss Ratings | LVRLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | E | |||
| Rating Factors | LVRLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Good | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Very Weak | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | LVRLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -1.02 | |||
| Price History | LVRLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 24.21% | |||
| 30-Day Total Return | 47.50% | |||
| 60-Day Total Return | 2.08% | |||
| 90-Day Total Return | 54.86% | |||
| Year to Date Total Return | 47.50% | |||
| 1-Year Total Return | -11.81% | |||
| 2-Year Total Return | -68.95% | |||
| 3-Year Total Return | -80.33% | |||
| 5-Year Total Return | -57.86% | |||
| 52-Week High % Change | -36.04% | |||
| 52-Week Low % Change | 593.07% | |||
| Price | LVRLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.11 | |||
| 52-Week Low Price | $0.01 | |||
| 52-Week Low Price (Date) | Jul 09, 2024 | |||
| 52-Week High Price (Date) | Aug 23, 2024 | |||
| Valuation | LVRLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 7.69M | |||
| Enterprise Value | 11.56M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.01 | |||
| Earnings Per Share Growth | -86.04% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.75 | |||
| Price/Book (Q) | -3.48 | |||
| Enterprise Value/Revenue (TTM) | 1.12 | |||
| Price | $0.06 | |||
| Enterprise Value/EBITDA (TTM) | 55.91 | |||
| Enterprise Value/EBIT | -102.31 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | LVRLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 109.73M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | LVRLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 917 843 2169 | |||
| Address | 217 Queen Street West Toronto, ON M5V 0R2 | |||
| Website | www.cordovacann.com | |||
| Country | Canada | |||
| Year Founded | 1997 | |||
| Profitability | LVRLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -1.09% | |||
| Profit Margin | -6.55% | |||
| Management Effectiveness | LVRLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -0.98% | |||
| Return on Equity | -- | |||
| Income Statement | LVRLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 10.28M | |||
| Total Revenue (TTM) | 10.28M | |||
| Revenue Per Share | $0.09 | |||
| Gross Profit (TTM) | 2.83M | |||
| EBITDA (TTM) | 206.80K | |||
| EBIT (TTM) | -113.00K | |||
| Net Income (TTM) | -673.70K | |||
| Net Income Avl. to Common (TTM) | -673.70K | |||
| Total Revenue Growth (Q YOY) | 3.72% | |||
| Earnings Growth (Q YOY) | 162.12% | |||
| EPS Diluted (TTM) | -0.01 | |||
| EPS Diluted Growth (Q YOY) | 139.29% | |||
| Balance Sheet | LVRLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 437.90K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 1.34M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -1.70M | |||
| Current Ratio (Q) | 0.198 | |||
| Book Value Per Share (Q) | -$0.02 | |||
| Total Assets (Q) | 6.76M | |||
| Total Current Liabilities (Q) | 6.78M | |||
| Total Debt (Q) | 3.93M | |||
| Total Liabilities (Q) | 8.46M | |||
| Total Common Equity (Q) | -2.20M | |||
| Cash Flow | LVRLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 66.20K | |||
| Cash from Financing (TTM) | -882.00K | |||
| Net Change in Cash (TTM) | -37.00K | |||
| Levered Free Cash Flow (TTM) | 996.40K | |||
| Cash from Operations (TTM) | 1.02M | |||
